LinkedIn image ad examples

I risultati clinici a 6 mesi di MiYOSMART iQ aprono possibilità rivoluzionarie per la miopia nei giovani. All'Asia-Pacific Academy of Ophthalmology Congress 2026 di Hong Kong, HOYA Vision Care ha presentato risultati clinici che cambiano radicalmente la conversazione sulla miopia infantile. Con MiYOSMART iQ, non si parla più solo di rallentare la progressione miopica. I dati clinici interim a 6 mesi indicano un nuovo scenario: in media, nessuna progressione della miopia nei giovani tra i 4 e i 12 anni, accompagnata da crescita oculare minima. Risultati mai osservati prima con lenti basate su tecnologia D.I.M.S., che portano il controllo della miopia oltre i confini conosciuti fino ad oggi. Un traguardo che rappresenta il culmine di oltre dieci anni di ricerca e innovazione HOYA, oggi evoluta nel Triple Enhanced Design di MiYOSMART iQ. Quello che emerge non è solo un avanzamento tecnologico. È un cambio di paradigma: uno standard di cura che si innalza, una nuova era nella gestione della miopia, una prospettiva concreta per il futuro della visione dei giovani. #HOYA #ActNow #MiYOSMART

Che valore ha la tecnologia quando è supportata dagli strumenti giusti? Nel 2026, HOYA Vision Care rinnova la partnership globale con NIDEK, punto di riferimento internazionale per la strumentazione oftalmica. Una collaborazione attiva da tre anni che entra oggi in una nuova fase, con lo sviluppo di innovazioni congiunte di Ricerca & Sviluppo pensate per offrire ai Professionisti della Visione soluzioni sempre più integrate, affidabili ed evolute. Per HOYA, l’innovazione non si esaurisce nella lente: significa costruire un ecosistema tecnologico. #HOYA John Goltermann Lassen Lasse, Mr. Motoki Ozawa

Pharmaceutical labels may serve the same purpose globally. But they are structured, interpreted, and regulated very differently. From section formats to safety communication requirements, each market brings its own nuances. Without a clear approach to managing these differences, consistency becomes difficult to sustain. This whitepaper provides a comparative view of major markets and highlights how organizations can align core information while adapting to regional expectations. Understand what drives variation, and how to manage it effectively.

What does it take to build resilient, high-performing medical writing teams today? In this blog, industry leaders from AbbVie and Merck share practical strategies for strengthening resourcing models in medical writing groups. From structured rotations that deepen document expertise to experience grids that transform project staffing, and mentoring approaches that build future-ready talent. If you're looking to balance quality, efficiency, and team development, this is a must-read.

Broaden your knowledge as a physical therapist! Dive into the world of body composition analysis 🤿

Incision Assist maakt cruciale kennis over ingrepen, voorkeuren en werkwijzen gemakkelijk toegankelijk, ook voor nieuwe of minder ervaren medewerkers. Dat zorgt voor snellere zelfstandigheid en minder druk op collega’s die vandaag vaak het aanspreekpunt zijn. In een Nederlands ziekenhuis leidde dit tot: • Kortere inwerktijd voor nieuwe teamleden • Betere voorbereiding bij medewerkers • Minder tijdsinvestering van ervaren personeel tijdens het inwerktraject van nieuwe medewerkers Een toekomstgerichte manier om teams efficiënter in te zetten, zelfs bij personeelswissels of tijdelijke krachten. Lees hoe Assist onboarding in de OK structureel ondersteunt.

Are you managing a consultant across multiple sites & multiple systems? How does one diary, every location & no cross-referencing sound?

Billing delays cost your practice more than time. iMedDoc connects directly to Healthcode, meaning there's no chasing and no gaps.

Skontaktuj się z nami, używając formularza w linku poniżej, jeśli uważasz, że Twoi pacjenci z zaawansowanym czerniakiem mogą kwalifikować się do 3 fazy badania klinicznego TEBE-AM.

Your advanced melanoma patients could be eligible for our Phase 3 clinical trial investigating T cell receptor therapy, designed to kill cancer cells. Patients may be eligible if they meet the following criteria: • At least 18 years of age • Have Stage IV or unresectable Stage III melanoma • Are HLA-A*02:01 positive • Have progressed on current or prior treatment for advanced melanoma

Inspira received a $390,000 payment for an AME system purchase order from a premier APAC university recognized for quantum computing and quantum information networks, establishing recurring revenue from consumables and annual service fees. Read more >> https://lnkd.in/dQnXxSJA

If you're looking to jumpstart your antibody drug conjugate CDx project with more accurate, reproducible, and information-rich biomarker analysis data, Indica Labs has the expertise and tools to make it happen. Our team has been developing AI algorithms for oncology and immuno-oncology across a variety of imaging modalities, tissue types, and application areas since our founding in 2011, providing unbiased quantitative biomarker expression and spatial data that drive ADC development.

What if one pipette could handle your entire workflow? Manual precision for the steps that need control. Electronic repeat dispensing for the steps that need speed. The INTEGRA SWITCH is the first hybrid handheld pipette that does both — without programming, without complexity, and at a price comparable to a traditional manual pipette.

Switching between a manual and electronic pipette mid-protocol breaks your flow. It adds time, adds fatigue, and adds complexity you don't need. The INTEGRA SWITCH combines both in one instrument — manual control when you need precision, electronic repeat dispensing when you need speed. No programming. No switching. No compromise.

Inspira and Qarakal signed a Joint Development Agreement to test and evaluate Inspira’s QTREX AME technology under quantum-relevant cryogenic conditions in a working superconducting quantum environment. Read more >> https://lnkd.in/dRxEiKVs

Institut Curie pathologists “addicted” to Ibex! ☺️ Dr. Anne Vincent-Salomon shares their experience of Ibex Medical Analytics reporting outstanding quality at #USCAP2026 USCAP - United States and Canadian Academy of Pathology

Will you be at #ASCO26? Connect with Indica Labs’ VP of Precision Medicine, Doug Bowman, to discuss the evolving role of AI-powered digital pathology in companion diagnostic development. Together with our partners at Leica Biosystems, we are transforming the future of precision medicine through comprehensive and seamless CDx co-development, helping partners move from tissue insight to actionable precision medicine strategies with greater confidence.

Is your backlog hiding high-risk GI cases? In many systems, gastric biopsies classified as "routine" can face wait times exceeding 60 working days - a delay that can significantly impact patient outcomes. This NHS Wales based study, authored by Dr. Muhammad Aslam, Angie Phillips & team at Betsi Cadwaladr University Health Board, proves how Ibex Medical Analytics AI-driven triage can accurately identify high-risk cases currently hidden in backlogs. By prioritizing these cases for earlier review, we are helping clinicians move from "waiting" to "treating." I've been speaking with many lab directors lately about backlogs, and this study provides a real blueprint for the solution. The full breakdown of the NHS Wales diagnostic transformation is worth a read: https://lnkd.in/ek--K6sV #HealthTech #Pathology #ClinicalAI #Innovation #USCAP2026 #DigitalPathology #NHS #CancerCare #MedTech #AI #NHSWales

ARTIFICIALIRIS Hands-on-Drylab – live auf der DOC 2026 Erleben Sie die ARTIFICIALIRIS aus nächster Nähe und erhalten Sie exklusive Einblicke in Design, Materialeigenschaften und Handling im klinischen Alltag. Bei unseren kompakten Live-Demonstrationen haben Sie die Möglichkeit, sich direkt mit dem HumanOptics ARTIFICIALIRIS Team auszutauschen und Ihre Fragen aus erster Hand beantworten zu lassen. Highlights: ✅ Live-Demonstration der ARTIFICIALIRIS ✅ Produktdetails & praktische Handhabung ✅ Klinische Tipps & Erfahrungen aus dem OP-Alltag ✅ Direkter Austausch mit dem Expertenteam ✅ Kostenfreie Teilnahme 📍 DOC 2026 | Nürnberg, Stand C2, direkt am Eingang der Halle 7A 18. Juni 2026 • 12:15–13:00 Uhr • 13:00–13:45 Uhr • 16:15–17:00 Uhr 19. Juni 2026 • 09:00–09:45 Uhr • 13:00–13:45 Uhr • 16:15–17:00 Uhr 20. Juni 2026 • 09:00–09:45 Uhr • 12:15–13:00 Uhr • 13:15–14:00 Uhr • 14:15–15:00 Uhr Die Plätze sind limitiert — jetzt kostenlos registrieren! https://lnkd.in/dvgPZ6hr #DOC2026 #ArtificialIris #Ophthalmologie #ProductDemo #Augenchirurgie #MedicalEducation #HumanOptics

Kostenloses Hands-on Drylab: Intrakapsuläre ARTIFICIALIRIS Implantation Nutzen Sie die Gelegenheit, Ihre chirurgischen Fähigkeiten im Bereich der intrakapsulären artifiziellen Irisimplantation gezielt zu erweitern — praxisnah, kompakt und direkt anwendbar. Unter der Leitung von Dr. med. Erik Chankiewitz erwartet Sie ein intensives Hands-on Training mit Fokus auf: ✅ Chirurgische Technik ✅ Sicheren Umgang mit der ARTIFICIALIRIS im Kapselsack ✅ Praktische Tipps aus der klinischen Anwendung ✅ Direkten fachlichen Austausch 📍 DOC 2026 | Nürnberg, Stand C2, direkt am Eingang der Halle 7A 18. Juni 2026 🕑 14:00–15:00 Uhr 🕒 15:00–16:00 Uhr Die Teilnahme ist kostenlos. Die Plätze sind limitiert — jetzt schnell anmelden! 👉 https://lnkd.in/dvgPZ6hr #DOC2026 #ArtificialIris #Drylab #Ophthalmologie #Augenchirurgie #MedicalEducation #HandsOnTraining #HumanOptics

Great surgeons continuously learn. Watch how experts approach every phase of a procedure and refine your skills at any level. Register now to access the Masters Video Library.

Curated video playlists tailored to your needs—explore each phase of a procedure with focused content and refine your skills. Register now to access the Masters Video Library.

Si administras una clínica con 2 o más médicos, cada uno puede ahorrar hasta 2 horas diarias en documentación. Eso son 40+ horas al mes POR MÉDICO que podrían dedicarse a consultas. Dragon Medical One es la IA de dictado médico de Microsoft. 99% de precisión. 90+ especialidades. Funciona con tu sistema actual. Más de 6,000 médicos ya lo usan. ¿Cuántas horas podría recuperar tu equipo?

Most "Global PV Networks" are just a patchwork of independent local vendors, coordinated loosely by a “mother” provider. Different SOPs. Different QMS. Inconsistent security and quality standards. No true harmonization, leaving global consistency unmet. Insuvia is different. Our Unified Governance Model delivers direct, global coverage. No subcontractors. No fragmented processes. Just one integrated framework, one QMS, one IT system – transparency and control built in for all markets.